文献速递胃肠动力与功能性疾病

COVID-19后长期胃肠道后遗症:一项前瞻性随访队列研究

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-10-21

这项前瞻性队列研究纳入320例COVID-19患者及两组健康对照(A组320例健康配偶/家属,B组280例COVID血清学阴性健康者),在1、3、6个月用罗马IV标准评估感染后功能性胃肠病/肠-脑互动障碍(PI-FGID/DGBI)。1个月36例(11.3%)出现FGID症状,3个月27例(8.4%)、6个月21例(6.6%)症状持续;健康对照随访至6个月均未发生FGID(P < .01)。预测因素为感染严重程度(P < .01)和感染时存在胃肠道症状(P < .01)。

要点

  • COVID-19患者1个月11.3%、3个月8.4%、6个月6.6%出现或持续FGID症状。
  • 3个月时以肠易激综合征2.5%、功能性腹泻2.2%、功能性消化不良1.9%为主。
  • 健康对照随访6个月均未发生FGID(P < .01)。

核心结论

  • COVID-19患者在3个月和6个月随访时新发PI-FGID/DGBI的数量显著高于健康对照。
  • 作者认为若进一步检查,部分患者可诊断潜在的吸收不良。

研究设计与样本

  • 前瞻性随访队列研究,纳入320例COVID-19病例、A组320例健康配偶/家属对照和B组280例COVID血清学阴性健康对照。
  • 在1、3、6个月使用经验证的罗马IV标准评估PI-FGID/DGBI的频率。

主要发现

  • 320例病例中,1个月36例(11.3%)出现FGID症状,3个月27例(8.4%)、6个月21例(6.6%)症状持续。
  • 3个月时8例(2.5%)为肠易激综合征,7例(2.2%)为功能性腹泻,6例(1.9%)为功能性消化不良,3例(0.9%)为功能性便秘,2例(0.6%)为功能性消化不良-肠易激综合征重叠,1例(0.3%)为功能性腹胀/膨隆。
  • 3个月时有症状者中,8例(29.6%)为单纯碳水化合物吸收不良阳性,1例(3.7%)为感染后吸收不良综合征阳性,1例(3.7%)为肠道产甲烷菌过度生长阳性。
  • 健康对照随访至6个月均未发生FGID(P < .01)。
  • 3个月和6个月的预测因素为感染严重程度(P < .01)和感染时存在胃肠道症状(P < .01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) is associated with long-term gastrointestinal sequelae; however, prospective longitudinal data are sparse. We prospectively studied the frequency, spectrum, and risk factors of post infection functional gastrointestinal disorders/disorders of gut-brain interaction (PI-FGID/DGBI) after COVID-19. METHODS: Three hundred twenty cases with COVID-19 and 2 control groups, group A, 320 healthy spouses/family controls, and group B, 280 healthy COVID serology-negative controls, were prospectively followed up at 1, 3, and 6 months by using validated Rome IV criteria to evaluate the frequency of PI-FGID/DGBI. RESULTS: Of 320 cases, at 1 month 36 (11.3%) developed FGID symptoms. Persistent symptoms were noted in 27 (8.4%) at 3 months and in 21 (6.6%) at 6 months. At 3 months, 8 (2.5%) had irritable bowel syndrome, 7 (2.2%) had functional diarrhea, 6 (1.9%) had functional dyspepsia, 3 (0.9%) had functional constipation, 2 (0.6%) had functional dyspepsia-IBS overlap, and 1 (0.3%) had functional abdominal bloating/distention. Among symptomatic individuals at 3 months, 8 (29.6%) were positive for isolated carbohydrate malabsorption, 1 (3.7%) was positive for post infection malabsorption syndrome, and 1 (3.7%) was positive for intestinal methanogen overgrowth. None of the healthy controls developed FGID up to 6 months of follow-up (P < .01). Predictive factors at 3 and 6 months were severity of infection (P < .01) and presence of gastrointestinal symptoms at the time of infection (P < .01). CONCLUSIONS: COVID-19 led to significantly higher number of new onset PI-FGID/DGBI compared with healthy controls at 3 and 6 months of follow-up. If further investigated, some patients can be diagnosed with underlying malabsorption.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Golla R, Vuyyuru S, Kante B, et al. Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study. Clin Gastroenterol Hepatol. 2022. PMID: 36273799. doi:10.1016/j.cgh.2022.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。